Rapid-Acting Treatments for Pediatric Depression and Suicidality: Where are We Now?

Tuesday, March 8, 2022, 2:00 pm EST
Meet the Scientist - March 2022

The field of rapid-acting treatments for depression and suicidality has grown considerably for adult treatment-resistant depression over the past 20 years. Despite increasing rates of pediatric depression and anxiety, and rising youth suicide rates, the evidence base for rapid-acting treatments for children and adolescents is only starting to form. In this webinar Dr. Dwyer will discuss the current data available for rapid-acting treatments in pediatric patients. She will identify the key questions that require more research and highlight ways that her team is working to address these knowledge gaps.

Watch webinar recording:

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for other upcoming webinars.

View past webinar recordings.

Presented by 
Jennifer Dwyer, M.D., Ph.D.
Jennifer Dwyer, M.D., Ph.D.

Assistant Professor; Co-Director and Co-Founder of the Pediatric Depression Clinic

Yale School of Medicine

2020 Young Investigator Grant

Dr. Dwyer completed her MD and PhD (Pharmacology) at the Univ. of California, Irvine, where she studied the development of the dopamine system in adolescence. She works clinically with children and adults, with a broad interest in how the brain and mind develop over time. She studies treatment-refractory adolescent depression, and hopes to better predict who will respond to different types of treatments, ranging from intensive psychotherapies to novel pharmacotherapeutics (e.g. ketamine).

Moderated by 
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation

President and CEO

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.